amifampridine has been researched along with Dysesthesia in 2 studies
Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Side-effects included initial perioral paresthesia and, later, paresthesia down the skin and along the ulnar edge of the forearm." | 1.28 | [Long-term treatment of Lambert-Eaton syndrome by 3, 4 diaminopyridine]. ( Forrett-Kaminsky, MC; Jost, WH; Mielke, U; Schimrigk, K, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wirtz, PW | 1 |
| Titulaer, MJ | 1 |
| Gerven, JM | 1 |
| Verschuuren, JJ | 1 |
| Jost, WH | 1 |
| Mielke, U | 1 |
| Forrett-Kaminsky, MC | 1 |
| Schimrigk, K | 1 |
1 review available for amifampridine and Dysesthesia
| Article | Year |
|---|---|
3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Action Potentials; Amifampridine; Calcium Channels; Cholinergic Agents; Clinical Pr | 2010 |
1 other study available for amifampridine and Dysesthesia
| Article | Year |
|---|---|
[Long-term treatment of Lambert-Eaton syndrome by 3, 4 diaminopyridine].
Topics: 4-Aminopyridine; Amifampridine; Electromyography; Humans; Lambert-Eaton Myasthenic Syndrome; Male; M | 1992 |